Comparison of the influence of CYP2C19 polymorphism on the effect of rabeprazole and omeprazole during the early healing phase of gastric ulcer

被引：0
|
作者：
Ando, T
Kato, H
Kajikawa, H
Isozaki, Y
Sugimoto, N
Seto, N
Nagao, Y
Hongo, H
Furuki, T
Takamori, S
Shimozawa, M
Yoshikawa, T
机构：
来源：
GASTROENTEROLOGY | 2002年 / 122卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
W827
引用
收藏
页码：A514 / A514
页数：1
相关论文
共 50 条
  • [1] A Comparative Study on Endoscopic Ulcer Healing of Omeprazole Versus Rabeprazole with Respect to CYP2C19 Genotypic Differences
    Takashi Ando
    Haruki Kato
    Naohito Sugimoto
    Yasuyuki Nagao
    Nobuyuki Seto
    Hitoshi Hongo
    Hirokazu Kajikawa
    Yutaka Isozaki
    Makoto Shimozawa
    Yuji Naito
    Norimasa Yoshida
    Takashi Ishizaki
    Toshikazu Yoshikawa
    Digestive Diseases and Sciences, 2005, 50 : 1625 - 1631
  • [2] A comparative study on endoscopic ulcer healing of omeprazole versus rabeprazole with respect to CYP2C19 genotypic differences
    Ando, T
    Kato, H
    Sugimoto, N
    Nagao, Y
    Seto, N
    Hongo, H
    Kajikawa, H
    Isozaki, Y
    Shimozawa, M
    Naito, Y
    Yoshida, N
    Ishizaki, T
    Yoshikawa, T
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (09) : 1625 - 1631
  • [3] Endoscopic analysis of gastric ulcer after one week's treatment with omeprazole and rabeprazole in relation to CYP2C19 genotype
    Ando, Takashi
    Ishikawa, Takeshi
    Kokura, Satoshi
    Naito, Yuji
    Yoshida, Norimasa
    Yoshikawa, Toshikazu
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (04) : 933 - 937
  • [4] Endoscopic Analysis of Gastric Ulcer after One Week's Treatment with Omeprazole and Rabeprazole in Relation to CYP2C19 Genotype
    Takashi Ando
    Takeshi Ishikawa
    Satoshi Kokura
    Yuji Naito
    Norimasa Yoshida
    Toshikazu Yoshikawa
    Digestive Diseases and Sciences, 2008, 53 : 933 - 937
  • [5] Effect of CYP2C19 polymorphism on rabeprazole induced nocturnal acid breakthrough
    Park, SH
    Kim, JW
    Lee, SY
    Choi, MG
    Kim, JK
    Choi, KY
    Chung, IS
    Sun, HS
    Park, DH
    GASTROENTEROLOGY, 2001, 120 (05) : A435 - A435
  • [6] Rabeprazole experience in Korea;: focus on CYP2C19 polymorphism
    Park, SH
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 : S20 - S21
  • [7] Influence of CYP2C19 Polymorphism on Lansoprazole and Rabeprazole Maintenance Treatment of Reflux Esophagitis
    Koike, Tomoyuki
    Iijima, Katsunori
    Imatani, Akira
    Shimosegawa, Tooru
    GASTROENTEROLOGY, 2010, 138 (05) : S655 - S655
  • [8] Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19
    Yu, KS
    Yim, DS
    Cho, JY
    Park, SS
    Park, JY
    Lee, KH
    Jang, IJ
    Yi, SY
    Bae, KS
    Shin, SG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (04) : 266 - 273
  • [9] The influence of CYP2C19 polymorphism on the eradication of Helicobacter pylori:: A randomized study of lansoprazole and rabeprazole
    Jung, H. Y.
    Song, H. J.
    Choi, K. D.
    Chung, J. W.
    Kim, D. H.
    Kim, J. H.
    HELICOBACTER, 2007, 12 (04) : 429 - 429
  • [10] CYP2C19 polymorphism has no influence on rabeprazole-based sequential or hybrid therapy
    Lin, T. J.
    Lin, C. L.
    Lee, H. C.
    Wang, C. K.
    Chen, K. Y.
    Wu, D. C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 118 - 118
12345